Combined P16INK4A and human papillomavirus testing improves the prediction of cervical intraepithelial neoplasia (CIN II-III) in Thai patients with low-grade cytological abnormalities

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 7, 2011, Pages 1777-1783

  Ekalaksananan, Tipaya ^a   Pientong, Chamsai ^a   Kongyingyoes, Bunkerd ^a   Chaiwongkot, Arkom ^a   Yuenyao, Pissamai ^a   Kleebkaow, Pilaiwan ^a   Kritpetcharat, Onanong ^a   Evans, Mark F ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Ascus; Cin; Hpvdetection; Lsil; P16ink4a detection

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; VIRUS DNA;

ADULT; AGED; ALPHAPAPILLOMAVIRUS; ARTICLE; EVALUATION; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; THAILAND; UTERINE CERVIX CARCINOMA IN SITU; VAGINA SMEAR; VIROLOGY;

ADULT; AGED; ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; THAILAND; VAGINAL SMEARS; YOUNG ADULT;

EID: 84864120721     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Baseman JG, Koutsky LA (2005). The epidemiology of human papillomavirus infections. J Clin Virol, 32 Suppl 1, S16-24.
2. Bibbo M, Klump WJ, DeCecco J, et al (2002). Procedure for immunocytochemical detection of P16INK4A antigen in thin- layer, liquid-based specimens. Acta Cytol, 46, 25-9.
3. Casas-Cordero M, Morin C, Roy M, et al (1981). Origin of the koilocyte in condylomata of the human cervix: ultrastructural study. Acta Cytol, 25, 383-92.
4. Castle PE, Solomon D, Schiffman M, et al (2005). Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. J Natl Cancer Inst, 97, 1066-71.
5. Chaiwongkot A, Pientong C, Ekalaksananan T, et al (2007). Evaluation of Primers and PCR Performance on HPV DNA Screening in Normal and Low Grade Abnormal Cervical Cells. Asian Pac J Cancer Prev, 8, 279-82.
6. Dillner J, Rebolj M, Birembaut P, et al (2008). Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. British Medical Journal, 377, a1754.
7. Denton KJ, Bergeron C, Klement P, et al (2010). The sensitivity and specificity of p16(INK4a) cytology vs HPV testing for detecting high-grade cervical disease in the t riage of ASC-US and LSIL pap cytology results. Am J Clin Pathol, 134, 12-21.
8. Fahey MT, Irwig L, Macaskill P (1995). Meta-analysis of Pap test accuracy. Am J Epidemiol, 141, 680-9.
9. Gonzalez-Bosquet E, Selva L, Sabria J, et al (2010). Predictive factors for the detection of CIN II-III in the follow-up of women with CIN I. Eur J Gynaecol Oncol, 31, 369-71.
10. Huang MZ, Huang S, Li DQ, et al (2010). The study of the combination detection of HPV-DNA and p16(INK4a) in cervical lesions. Med Oncol. Nov 4 [Epub ahead of print].
11. Holladay EB, Logan S, Arnold J, et al (2006). A comparison of the clinical utility of p16(INK4a) immunolocalization with the presence of human papillomavirus by hybrid capture 2 for the detection of cervical dysplasia/neoplasia. Cancer, 108, 451-61.
12. Juric D, Mahovlic V, Rajhvajn S, et al (2010). Liquid-based cytology--new possibilities in the diagnosis of cervical lesions. Coll Antropol, 34, 19-24.
13. Kang S, Kim J, Kim H B, et al (2006). Methylation of p16INK4a is a non-rare event in cervical intraepithelial neoplasia. Diagn Mol Pathol, 15, 74-82.
14. Kaufman RH (2001). Is there a role for human papillomavirus testing in clinical practice? Obstet Gynecol, 98, 724-25.
15. Kiatiyosnusorn R, Suprasert P, Srisomboon J, et al (2010). High-grade histologic lesions in women with low-grade squamous intraepithelial lesion cytology from a region of Thailand with a high incidence of cervical cancer. Int J Gynaecol Obstet, 110, 133-6.
16. Kjaer S K, van den Brule A J, Paull G, et al (2002). Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. Bmj, 325, 572.
17. Klaes R, Benner A, Friedrich T, et al (2002). p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol, 26, 1389-99.
18. Klaes R, Friedrich T, Spitkovsky D, et al (2001). Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer, 92, 276-84.
19. Kuhler-Obbarius C, Milde-Langosch K, Loning T, et al (1994). Polymerase chain reaction-assisted evaluation of low and high grade squamous intraepithelial lesion cytology and reappraisal of the Bethesda System. Acta Cytol, 38, 681-6.
20. Kurman RJ, Henson DE, Herbst AL, et al (1994). Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA, 271, 1866-9.
21. Lonky N M (1999). Perspectives in cervical cancer prevention and health services management. J Lower Genital Tract Dis, 3, 123-30.
22. Lytwyn A, Sellors JW, Mahony JB, et al (2000). Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group. Cmaj, 163, 701-7.
23. Manos MM, Kinney WK, Hurley LB, et al (1999). Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. Jama, 281, 1605-10.
24. Morin C, Bairati I, Bouchard C, et al (2001). Managing atypical squamous cells of undetermined significance in Papanicolaou smears. J Reprod Med, 46, 799-805.
25. Nanda K, McCrory DC, Myers ER, et al (2000). Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med, 132, 810-9.
26. Nasioutziki M, Daniilidis A, Dinas K, et al (2011). The evaluation of p16INK4a immunoexpression/immunostaining and human papillomavirus DNA test in cervical liquid-based cytological samples. Int J Gynecol Cancer, 21, 79-85.
27. Nyirjesy I, Billingsley FS, Forman MR (1998). Evaluation of atypical and low-grade cervical cytology in private practice. Obstet Gynecol, 92, 601-7.
28. Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
29. Pientong C, Ekalaksananan T, Kongyingyoes, B, et al (2004). Immunocytochemical staining of p16INK4a protein from conventional Pap test and its association with human papillomavirus infection. Diagn Cytopathol, 31, 235-42.
30. Sano T, Oyama T, Kashiwabara K, et al (1998). Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol, 153, 1741-8.
31. Saqi A, Pasha TL, McGrath CM, et al (2002). Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia. Diagn Cytopathol, 27, 365-70.
32. Sherman ME, Schiffman MH, Lorincz AT, et al (1994). Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. Am J Clin Pathol, 102, 182-7.
33. Slawson DC, Bennett JH, Simon LJ, et al (1994). Should all women with cervical atypia be referred for colposcopy: a HARNET study. Harrisburgh Area Research Network. J Fam Pract, 38, 387-92.
34. Solomon D, Schiffman M, Tarone R (2001). Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst, 93, 293-9.
35. Sung CO, Kim SR, Oh YL, et al (2009). The use of p16INK4a immunocytochemistry in "Atypical Squamous Cells Which Cannot Exclude HSIL" compared With "Atypical Squamous Cells of Undetermined Significance" in liquid-based cervical smears. Diagn Cytopathol, 38, 168-71.
36. Tarkkanen J, Auvinen E, Nieminen P, et al (2007). HPV DNA testing as an adjunct in the management of patients with low grade cytological lesions in Finland. Acta Obstet Gynecol Scand, 86, 367-72.
37. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group (2000). Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst, 92, 397-402.
38. Tsoumpou I, Arbyn M, Kyrgiou M (2009). p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev, 35, 210-20.
39. van den Brule AJ, Pol R, Fransen-Daalmeijer N, et al (2002). GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol, 40, 779-87.
40. Virmani AK, Muller C, Rathi A, et al (2001). Aberrant methylation during cervical carcinogenesis. Clin Cancer Res, 7, 584-9.
41. Volgareva G, Zavalishina L, Andreeva Y (2004). Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells. BMC Cancer, 4, 58.
42. Volgareva GM, Zavalishina LE, Frank GA, et al (2002). Expression of the protein marker p16INK4a in the cervix uteri cancer. Arkh Patol, 64, 22-4.
43. Wright TCJr, Cox JT, et al (2002). 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA, 287, 2120-9.
44. Yarandi F, Izadi Mood N, Mirashrafi F, et al (2004). Colposcopic and histologic findings in women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Aust N Z J Obstet Gynaecol, 44, 514-6.
45. Zuna RE, Wang SS, Schiffman M, et al (2006). Comparison of human papillomavirus distribution in cytologic subgroups of low-grade squamous intraepithelial lesion. Cancer, 108, 288-97.
46. zur Hausen H (2002). Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer, 2, 342-50.